ABVC BioPharma, Inc.
ABVC Healthcare Biotechnology
ABVC BioPharma, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $509,600.00, up 234.4% from fiscal 2023. In the quarter to June 2026, revenue grew 66,233.3%, EPS grew 76.9% and free cash flow grew 72.7%, each against the same quarter a year earlier.
Follow ABVC
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Net Income |
(0.81) | (1.69) | (3.02) | (2.08) |
+8 more quarters Free account |
Depreciation & Amortization |
0.09 | 0.09 | 0.21 | 0.10 | |
Non Cash Items (Other) |
0.28 | 0.82 | 2.25 | 1.22 | |
Change in inventories |
— | — | 0.00 | 0.00 | |
Change in payables and accrued liability |
0.05 | (0.01) | 0.16 | (0.03) | |
Income tax paid |
(0.01) | (0.01) | — | (0.02) | |
Change in other assets and liabilities |
0.16 | (0.10) | (0.19) | (0.14) | |
Operating Cash Flow |
(0.24) | (0.89) | (0.59) | (0.96) | |
Long-Term Investments Change (Net) |
0.01 | (0.68) | — | — | |
Other investing activities |
(0.11) | 0.73 | (0.03) | (0.51) | |
Investing cash flow |
(0.10) | 0.05 | (0.03) | (0.51) | |
Repayment/Issuance of Debt (Net) |
0.07 | (0.76) | 0.55 | (0.16) | |
Equity Repurchase (Common, Net) |
0.32 | 0.10 | 0.53 | 1.32 | |
Other financial activities |
(0.17) | 0.32 | — | (0.03) | |
Financing cash flow |
0.23 | (0.34) | 1.08 | 1.20 | |
Exchange Rate Adjustment |
0.01 | 0.00 | 0.01 | 0.05 | |
Change in Cash |
(0.11) | (1.19) | 0.47 | (0.22) | |
Beginning Cash |
0.00 | 1.33 | 0.00 | 0.00 | |
Ending Cash |
(0.11) | 0.14 | 0.47 | (0.22) | |
Stock Based Compensation |
0.25 | 0.79 | 1.39 | 1.14 | |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Cash/Marketcap |
— | — | — | 0.00 | |
Assets Liabilities Change (Total) |
0.20 | (0.12) | (0.04) | (0.19) | |
Investments Change (Net) |
0.01 | (0.68) | — | — | |
Issuance/Purchase of Shares |
0.32 | 0.10 | 0.53 | 1.32 |